117 related articles for article (PubMed ID: 7008508)
1. 24-hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. A comparison between closed- and open-loop systems.
Deckert T; Bojsen J; Christiansen JS; Kølendorf K; Svendsen PA; Andersen AR
Acta Med Scand; 1980; 208(6):451-8. PubMed ID: 7008508
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
[TBL] [Abstract][Full Text] [Related]
3. Programmable open-loop micropump insulin delivery system.
Clemens AH
Diabetes Care; 1980; 3(2):359-61. PubMed ID: 6993153
[TBL] [Abstract][Full Text] [Related]
4. Regulation of brittle diabetics by a pre-planned insulin infusion programme.
Deckert T; Lorup B
Diabetologia; 1976 Dec; 12(6):573-9. PubMed ID: 1001846
[TBL] [Abstract][Full Text] [Related]
5. [Use of an artificial B-cell in clinic and experimental medicine].
Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
[TBL] [Abstract][Full Text] [Related]
6. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
7. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
Froesch ER; Blatter G; Morell B
Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
[TBL] [Abstract][Full Text] [Related]
8. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.
Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS
Lancet; 1979 Jun; 1(8129):1255-7. PubMed ID: 87724
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
11. Long-term continuous subcutaneous insulin infusion in diabetics at home.
Pickup JC; White MC; Keen H; Parsons JA; Alberti KG
Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966
[TBL] [Abstract][Full Text] [Related]
12. Metabolic response of normal man and insulin-infused diabetics to postprandial exercise.
Nelson JD; Poussier P; Marliss EB; Albisser AM; Zinman B
Am J Physiol; 1982 May; 242(5):E309-16. PubMed ID: 7044140
[TBL] [Abstract][Full Text] [Related]
13. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the programming of an open-loop insulin infusion device from the biostator glucose controller.
Service FJ; Rizza RA; Westland RE; Hall LD; Nelson RL; Haymond MW; Clemens AH; Gerich JE
Diabetes Care; 1980; 3(2):278-84. PubMed ID: 6993141
[TBL] [Abstract][Full Text] [Related]
15. Control algorithms for artificial beta cell.
Clemens AH
Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
[TBL] [Abstract][Full Text] [Related]
16. Timing of insulin delivery with meals.
Kraegen EW; Chisholm DJ; McNamara ME
Horm Metab Res; 1981 Jul; 13(7):365-7. PubMed ID: 7024077
[TBL] [Abstract][Full Text] [Related]
17. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients.
Bruns W; Bombor H; Jutzi E; Ratzmann KP; Schulz B; Abel P; Fischer U
Diabetes Care; 1983; 6(2):112-7. PubMed ID: 6343014
[TBL] [Abstract][Full Text] [Related]
19. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
Beyer J; Wolf E; Cordes U; Hassingen W
Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.
Pickup JC; Keen H; Parsons JA; Alberti KG
Diabetologia; 1979 Jun; 16(6):385-9. PubMed ID: 467848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
